Recommendation ID
Current evidence on the safety and efficacy of implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes is limited in quality and quantity. Therefore the procedure should only be used in the context of research.
Any explanatory notes
(if applicable)
Further research should give details of patient selection, including information about use of the procedure in patients with different levels of BMI. The research should provide information on complications; reasons for early removal of the device; medication used for treating type 2 diabetes, both when the device is in place and after its removal; and control of type 2 diabetes after device removal. NICE may update the guidance on publication of further evidence.

Source guidance details

Comes from guidance
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
Date issued
March 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? Yes  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 23/04/2015